Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer

2021389 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT03594747.

Good health and well-being

Published in: JAMA Oncology

Volume 7, Issue 5, pp. 709-709

Field-Weighted Citation Impact: 27.20